NM_007255.3:c.50+1G>A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2

The NM_007255.3(B4GALT7):​c.50+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000000834 in 1,199,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 8.3e-7 ( 0 hom. )

Consequence

B4GALT7
NM_007255.3 splice_donor, intron

Scores

4
2
1
Splicing: ADA: 1.000
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.22

Publications

0 publications found
Variant links:
Genes affected
B4GALT7 (HGNC:930): (beta-1,4-galactosyltransferase 7) This gene is a member of the beta-1,4-galactosyltransferase (beta4GalT) family. Family members encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose. Each beta4GalT member has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus which then remains uncleaved to function as a transmembrane anchor. The enzyme encoded by this gene attaches the first galactose in the common carbohydrate-protein linkage (GlcA-beta1,3-Gal-beta1,3-Gal-beta1,4-Xyl-beta1-O-Ser) found in proteoglycans. This enzyme differs from other beta4GalTs because it lacks the conserved Cys residues found in beta4GalT1-beta4GalT6 and it is located in cis-Golgi instead of trans-Golgi. Mutations in this gene have been associated with the progeroid form of Ehlers-Danlos syndrome. [provided by RefSeq, Oct 2009]
B4GALT7 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, spondylodysplastic type, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
  • Ehlers-Danlos syndrome, spondylodysplastic type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.13109756 fraction of the gene. Cryptic splice site detected, with MaxEntScore 4.7, offset of 13, new splice context is: gcgGTgggc. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
B4GALT7NM_007255.3 linkc.50+1G>A splice_donor_variant, intron_variant Intron 1 of 5 ENST00000029410.10 NP_009186.1 Q9UBV7
B4GALT7XM_047416681.1 linkc.-1061+1G>A splice_donor_variant, intron_variant Intron 1 of 6 XP_047272637.1
B4GALT7XM_047416682.1 linkc.-346+1G>A splice_donor_variant, intron_variant Intron 1 of 6 XP_047272638.1
B4GALT7XM_047416680.1 linkc.-2225G>A upstream_gene_variant XP_047272636.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
B4GALT7ENST00000029410.10 linkc.50+1G>A splice_donor_variant, intron_variant Intron 1 of 5 1 NM_007255.3 ENSP00000029410.5 Q9UBV7

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
8.34e-7
AC:
1
AN:
1199404
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
584114
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24328
American (AMR)
AF:
0.00
AC:
0
AN:
16522
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54558
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
27962
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3410
European-Non Finnish (NFE)
AF:
0.00000102
AC:
1
AN:
978078
Other (OTH)
AF:
0.00
AC:
0
AN:
48248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Uncertain:1
Aug 21, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with B4GALT7-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 1 of the B4GALT7 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), however the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in B4GALT7 cause disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Pathogenic
0.19
CADD
Pathogenic
34
DANN
Uncertain
0.99
Eigen
Pathogenic
0.95
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Uncertain
0.89
D
PhyloP100
4.2
GERP RS
4.0
PromoterAI
-0.72
Under-expression
Mutation Taster
=3/97
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.93
SpliceAI score (max)
0.99
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.99
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr5-177027262; API